Trial Profile
Thalomid and Carboplatin for the Treatment of Pediatric Brain Stem Glioma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2019
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Thalidomide (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 24 Jun 2011 Additional lead trial centre and investigator identified as reported by ClinicalTrials.gov.
- 22 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Oct 2005 New trial record.